本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR
Kam Lawrence (CIK 1802765) reported $97.4M across 7 reported positions in its SEC 13F filing for 2019-12-31. Largest positions: ADVM ($46.6M, 47.83%), RGNX ($19.1M, 19.59%), SRPT ($14.5M, 14.93%), GNW ($9.2M, 9.48%), FENC ($5.4M, 5.56%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ADVM | ADVERUM BIOTECHNOLOGIES INC | $46.6M | 47.83% | 4.0M | New |
| 2 | RGNX | REGENXBIO INC | $19.1M | 19.59% | 465,664 | New |
| 3 | SRPT | SAREPTA THERAPEUTICS INC | $14.5M | 14.93% | 112,689 | New |
| 4 | GNW | GENWORTH FINL INC | $9.2M | 9.48% | 2.1M | New |
| 5 | FENC | FENNEC PHARMACEUTICALS INC | $5.4M | 5.56% | 834,689 | New |
| 6 | SPNT | THIRD PT REINS LTD | $2.4M | 2.45% | 227,185 | New |
| 7 | TROX | TRONOX HOLDINGS PLC | $149,000 | 0.15% | 13,055 | New |
来源：SEC 13F 申报文件 · 截至 2019-12-31